Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review

We had six cases of patients who were treated with long-term testosterone replacement therapy (TRT) after high dose-rate (HDR) brachytherapy and androgen deprivation therapy for high-risk prostate cancer. All patients were given testosterone enanthate by intramuscular injection every 3 to 4 weeks. B...

Full description

Bibliographic Details
Main Authors: Suguru Kadomoto, Kazuyoshi Shigehara, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Format: Article
Language:English
Published: Korean Society for Sexual Medicine and Andrology 2020-01-01
Series:The World Journal of Men's Health
Subjects: